| Accord Healthcare AG - Lenalidomid Accord 5 mg, Hartkapseln | | 67714 | | 02 | | Lenalidomid Accord 5 mg | | Hartkapseln | | L04AX04 | | Lenalidomide | | 15.01.2021 | | |
| | Composition | | lenalidomidum 5 mg, lactosum 33.46 mg, cellulosum microcristallinum, carmellosum natricum conexum corresp. natrium 0.014 mg, silica colloidalis anhydrica, magnesii stearas, Kapselhülle: E 171, gelatina, aqua, Drucktinte: lacca, E 172 (nigrum), kalii hydroxidum, E 171, E 172 (flavum), E 132, pro capsula. | | Packungsbestandteile | | Capsules | | | | | Principe actif | Concentr. |
|---|
| Lenalidomidum | 5 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Lenalidomidum | 5 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| | | | | | | | | Aqua | | | | | | | | | | | | | | color. | | | | color. | | | | color. | | Gelatina | | | | | | | | | | Drucktinte | | | 33.46 mg | | | | | | | | | | | Silica Colloidalis Anhydrica | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 002 | 21 | 707.76 | 786.15 | A | LS | Non |
|
|
